Search Results | NIH

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Search Results 2441 – 2460 of 3231

Management of Children Receiving Antiretroviral Therapy

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-pediatric-arv/management-children-receiving-antiretroviral

Hepatitis B Virus Infection

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/hepatitis-b-virus-infection

Care of Infants With Perinatal Exposure to HIV

https://clinicalinfo.hiv.gov/guidelines/perinatal/management-infants-born-people-hiv-infection

Antiretroviral Management of Infants With In Utero, Intrapartum, or Breastfeeding Exposure to HIV

https://clinicalinfo.hiv.gov/guidelines/perinatal/management-infants-utero-intrapartum-breastfeeding-hiv-exposure

Fosamprenavir (Lexiva, FPV)

https://clinicalinfo.hiv.gov/guidelines/perinatal/archived-drugs-fosamprenavir-lexiva

https://clinicalinfo.hiv.gov/guidelines/pediatric-arv/general-terms

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/introduction

Suboptimal CD4 Cell Recovery Despite Viral Suppression

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/suboptimal-cd4-cell-recovery

Hepatitis C Virus/HIV Coinfection

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/coinfections-hepatitis-c-virus-hiv

Raltegravir (Isentress, Isentress HD, RAL)

https://clinicalinfo.hiv.gov/guidelines/perinatal/safety-toxicity-arv-agents-integrase-inhibitors-raltegravir-isentress

Nucleoside and Nucleotide Analogue Reverse Transcriptase Inhibitors

https://clinicalinfo.hiv.gov/guidelines/perinatal-hiv-clinical-guidelines/nucleoside-and-nucleotide-analogue-reverse

Drug-Drug Interactions

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/drug-drug-interactions

Drug-Drug Interactions: Protease Inhibitors and Other Drugs

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/drug-interactions-protease-inhibitors

Laboratory Testing: Drug-Resistance Testing

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/drug-resistance-testing

Diagnosis of HIV Infection in Infants and Children

https://clinicalinfo.hiv.gov/guidelines/perinatal/management-infants-diagnosis-hiv-infection-children

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/introduction

Laboratory Testing: HLA-B* 5701 Screening

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/hla-b-5701-screening

https://clinicalinfo.hiv.gov/guidelines/pediatric-arv/introduction

Saquinavir (Invirase, SQV)

https://clinicalinfo.hiv.gov/guidelines/perinatal/archived-drugs-saquinavir-invirase

Drug-Drug Interactions: Integrase Strand Transfer Inhibitors and Other Drugs

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/drug-interactions-insti